Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.

Hellesnes, Ragnhild

Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era. [electronic resource] - International journal of cancer 07 2020 - 21-32 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-0215

10.1002/ijc.32704 doi


Adult
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cisplatin--administration & dosage
Cohort Studies
Humans
Incidence
Male
Middle Aged
Neoplasms, Germ Cell and Embryonal--drug therapy
Neoplasms, Second Primary--epidemiology
Norway--epidemiology
Registries
Risk
Testicular Neoplasms--drug therapy
Young Adult